Benchmark adjusted the firm’s price target on Agilon Health (AGL) to $13 from $1.50 and keeps a Buy rating on the shares to reflect this week’s 1:25 reverse stock split and adjustments to the firm’s model.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AGL: